APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Reproductive and Respiratory Syndrome Vaccine

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Selected research

Market Structure

Global Swine Reproductive and Respiratory Syndrome Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025197 pages

Choose your research edition.

Industry ResearchSwine Reproductive and Respiratory Syndrome Vaccine Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Reproductive and Respiratory Syndrome Vaccine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Swine Reproductive and Respiratory Syndrome Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Reproductive and Respiratory Syndrome Vaccine Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Reproductive and Respiratory Syndrome Vaccine Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Boehringer ingelheim is the company with the largest market share, about 25 percent.

This report provides an overview of the global Swine Reproductive and Respiratory Syndrome Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Swine Reproductive and Respiratory Syndrome Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Swine Reproductive and Respiratory Syndrome Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Swine Reproductive and Respiratory Syndrome Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Company

ASCENT CORPORATION

Boehringer-Ingelheim

MSD Animal Health

SPAH

Ceva

Chengdu TECH-BANK Biological Products Co,.Ltd

ringpu

QILU ANIMAL HEALTH PRODUCTS CO.,LTD

DAHUANONG

CAVAC

Komipharm

Agrovet

Bioveta

JINYU BIO-TECNOLOGY CO.,LTD

Phibro Animal Health

ANHUI TIANKANG(GROUP)SHRES O., LTD

Zoetis

WINSUN BIO

PULIKE BIOLOGICAL ENGINERING,INC.

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Type

Active Vaccine

Inactivated Vaccines

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Application

Government Tender

Market Sales

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Reproductive and Respiratory Syndrome Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Reproductive and Respiratory Syndrome Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Reproductive and Respiratory Syndrome Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Swine Reproductive and Respiratory Syndrome Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Swine Reproductive and Respiratory Syndrome Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Swine Reproductive and Respiratory Syndrome Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Swine Reproductive and Respiratory Syndrome Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Swine Reproductive and Respiratory Syndrome Vaccine Industry Trends Table 2. Swine Reproductive and Respiratory Syndrome Vaccine Industry Drivers Table 3. Swine Reproductive and Respiratory Syndrome Vaccine Industry Opportunities and Challenges Table 4. Swine Reproductive and Respiratory Syndrome Vaccine Industry Restraints Table 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Manufacturers Table 9. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers, Product Type & Application Table 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Swine Reproductive and Respiratory Syndrome Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Active Vaccine Table 17. Major Manufacturers of Inactivated Vaccines Table 18. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Government Tender Table 29. Major Manufacturers of Market Sales Table 30. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 32. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2027-2032) & (K Units) Table 33. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2026) & (K Units) Table 37. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2027-2032) & (K Units) Table 38. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 47. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2027-2032) & (K Units) Table 48. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 50. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2027-2032) & (K Units) Table 57. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2027-2032) Table 62. ASCENT CORPORATION Company Information Table 63. ASCENT CORPORATION Business Overview Table 64. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 66. ASCENT CORPORATION Recent Development Table 67. Boehringer-Ingelheim Company Information Table 68. Boehringer-Ingelheim Business Overview Table 69. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 71. Boehringer-Ingelheim Recent Development Table 72. MSD Animal Health Company Information Table 73. MSD Animal Health Business Overview Table 74. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 76. MSD Animal Health Recent Development Table 77. SPAH Company Information Table 78. SPAH Business Overview Table 79. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 81. SPAH Recent Development Table 82. Ceva Company Information Table 83. Ceva Business Overview Table 84. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 86. Ceva Recent Development Table 87. Chengdu TECH-BANK Biological Products Co,.Ltd Company Information Table 88. Chengdu TECH-BANK Biological Products Co,.Ltd Business Overview Table 89. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 91. Chengdu TECH-BANK Biological Products Co,.Ltd Recent Development Table 92. ringpu Company Information Table 93. ringpu Business Overview Table 94. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 96. ringpu Recent Development Table 97. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information Table 98. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Business Overview Table 99. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 101. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Development Table 102. DAHUANONG Company Information Table 103. DAHUANONG Business Overview Table 104. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 106. DAHUANONG Recent Development Table 107. CAVAC Company Information Table 108. CAVAC Business Overview Table 109. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 111. CAVAC Recent Development Table 112. Komipharm Company Information Table 113. Komipharm Business Overview Table 114. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 116. Komipharm Recent Development Table 117. Agrovet Company Information Table 118. Agrovet Business Overview Table 119. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 121. Agrovet Recent Development Table 122. Bioveta Company Information Table 123. Bioveta Business Overview Table 124. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 126. Bioveta Recent Development Table 127. JINYU BIO-TECNOLOGY CO.,LTD Company Information Table 128. JINYU BIO-TECNOLOGY CO.,LTD Business Overview Table 129. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 131. JINYU BIO-TECNOLOGY CO.,LTD Recent Development Table 132. Phibro Animal Health Company Information Table 133. Phibro Animal Health Business Overview Table 134. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 136. Phibro Animal Health Recent Development Table 137. ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information Table 138. ANHUI TIANKANG(GROUP)SHRES O., LTD Business Overview Table 139. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 141. ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Development Table 142. Zoetis Company Information Table 143. Zoetis Business Overview Table 144. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 146. Zoetis Recent Development Table 147. WINSUN BIO Company Information Table 148. WINSUN BIO Business Overview Table 149. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 151. WINSUN BIO Recent Development Table 152. PULIKE BIOLOGICAL ENGINERING,INC. Company Information Table 153. PULIKE BIOLOGICAL ENGINERING,INC. Business Overview Table 154. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 156. PULIKE BIOLOGICAL ENGINERING,INC. Recent Development Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Swine Reproductive and Respiratory Syndrome Vaccine Distributors List Table 160. Swine Reproductive and Respiratory Syndrome Vaccine Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Swine Reproductive and Respiratory Syndrome Vaccine Product Image Figure 2. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Swine Reproductive and Respiratory Syndrome Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Active Vaccine Image Figure 9. Inactivated Vaccines Image Figure 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Government Tender Image Figure 17. Market Sales Image Figure 18. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Swine Reproductive and Respiratory Syndrome Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Swine Reproductive and Respiratory Syndrome Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Swine Reproductive and Respiratory Syndrome Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Active Vaccine
  • Inactivated Vaccines
Applications
  • Government Tender
  • Market Sales
Companies covered
  • ASCENT CORPORATION
  • Boehringer-Ingelheim
  • MSD Animal Health
  • SPAH
  • Ceva
  • Chengdu TECH-BANK Biological Products Co,.Ltd
  • ringpu
  • QILU ANIMAL HEALTH PRODUCTS CO.,LTD
  • DAHUANONG
  • CAVAC
  • Komipharm
  • Agrovet
  • Bioveta
  • JINYU BIO-TECNOLOGY CO.,LTD
  • Phibro Animal Health
  • ANHUI TIANKANG(GROUP)SHRES O., LTD
  • Zoetis
  • WINSUN BIO
  • PULIKE BIOLOGICAL ENGINERING,INC.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Dynamics
  1. 2.1 Swine Reproductive and Respiratory Syndrome Vaccine Industry Trends
  2. 2.2 Swine Reproductive and Respiratory Syndrome Vaccine Industry Drivers
  3. 2.3 Swine Reproductive and Respiratory Syndrome Vaccine Industry Opportunities and Challenges
  4. 2.4 Swine Reproductive and Respiratory Syndrome Vaccine Industry Restraints
3 Swine Reproductive and Respiratory Syndrome Vaccine Market by Manufacturers
  1. 3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Swine Reproductive and Respiratory Syndrome Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Swine Reproductive and Respiratory Syndrome Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Swine Reproductive and Respiratory Syndrome Vaccine Tier 1, Tier 2, and Tier 3
4 Swine Reproductive and Respiratory Syndrome Vaccine Market by Type
  1. 4.1 Swine Reproductive and Respiratory Syndrome Vaccine Type Introduction
  2. 4.1.1 Active Vaccine
  3. 4.1.2 Inactivated Vaccines
  4. 4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type
  5. 4.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type
  9. 4.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2021-2032)
5 Swine Reproductive and Respiratory Syndrome Vaccine Market by Application
  1. 5.1 Swine Reproductive and Respiratory Syndrome Vaccine Application Introduction
  2. 5.1.1 Government Tender
  3. 5.1.2 Market Sales
  4. 5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application
  5. 5.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application
  9. 5.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2021-2032)
6 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region
  1. 6.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region
  1. 7.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region
  2. 7.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ASCENT CORPORATION
  2. 8.1.1 ASCENT CORPORATION Company Information
  3. 8.1.2 ASCENT CORPORATION Business Overview
  4. 8.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  6. 8.1.5 ASCENT CORPORATION Recent Developments
  7. 8.2 Boehringer-Ingelheim
  8. 8.2.1 Boehringer-Ingelheim Company Information
  9. 8.2.2 Boehringer-Ingelheim Business Overview
  10. 8.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  12. 8.2.5 Boehringer-Ingelheim Recent Developments
  13. 8.3 MSD Animal Health
  14. 8.3.1 MSD Animal Health Company Information
  15. 8.3.2 MSD Animal Health Business Overview
  16. 8.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  18. 8.3.5 MSD Animal Health Recent Developments
  19. 8.4 SPAH
  20. 8.4.1 SPAH Company Information
  21. 8.4.2 SPAH Business Overview
  22. 8.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  24. 8.4.5 SPAH Recent Developments
  25. 8.5 Ceva
  26. 8.5.1 Ceva Company Information
  27. 8.5.2 Ceva Business Overview
  28. 8.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  30. 8.5.5 Ceva Recent Developments
  31. 8.6 Chengdu TECH-BANK Biological Products Co,.Ltd
  32. 8.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Company Information
  33. 8.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Business Overview
  34. 8.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  36. 8.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments
  37. 8.7 ringpu
  38. 8.7.1 ringpu Company Information
  39. 8.7.2 ringpu Business Overview
  40. 8.7.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  42. 8.7.5 ringpu Recent Developments
  43. 8.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
  44. 8.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information
  45. 8.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Business Overview
  46. 8.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  48. 8.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments
  49. 8.9 DAHUANONG
  50. 8.9.1 DAHUANONG Company Information
  51. 8.9.2 DAHUANONG Business Overview
  52. 8.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  54. 8.9.5 DAHUANONG Recent Developments
  55. 8.10 CAVAC
  56. 8.10.1 CAVAC Company Information
  57. 8.10.2 CAVAC Business Overview
  58. 8.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  60. 8.10.5 CAVAC Recent Developments
  61. 8.11 Komipharm
  62. 8.11.1 Komipharm Company Information
  63. 8.11.2 Komipharm Business Overview
  64. 8.11.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  66. 8.11.5 Komipharm Recent Developments
  67. 8.12 Agrovet
  68. 8.12.1 Agrovet Company Information
  69. 8.12.2 Agrovet Business Overview
  70. 8.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  72. 8.12.5 Agrovet Recent Developments
  73. 8.13 Bioveta
  74. 8.13.1 Bioveta Company Information
  75. 8.13.2 Bioveta Business Overview
  76. 8.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  78. 8.13.5 Bioveta Recent Developments
  79. 8.14 JINYU BIO-TECNOLOGY CO.,LTD
  80. 8.14.1 JINYU BIO-TECNOLOGY CO.,LTD Company Information
  81. 8.14.2 JINYU BIO-TECNOLOGY CO.,LTD Business Overview
  82. 8.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  84. 8.14.5 JINYU BIO-TECNOLOGY CO.,LTD Recent Developments
  85. 8.15 Phibro Animal Health
  86. 8.15.1 Phibro Animal Health Company Information
  87. 8.15.2 Phibro Animal Health Business Overview
  88. 8.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  90. 8.15.5 Phibro Animal Health Recent Developments
  91. 8.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
  92. 8.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information
  93. 8.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Business Overview
  94. 8.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  96. 8.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments
  97. 8.17 Zoetis
  98. 8.17.1 Zoetis Company Information
  99. 8.17.2 Zoetis Business Overview
  100. 8.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  102. 8.17.5 Zoetis Recent Developments
  103. 8.18 WINSUN BIO
  104. 8.18.1 WINSUN BIO Company Information
  105. 8.18.2 WINSUN BIO Business Overview
  106. 8.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  108. 8.18.5 WINSUN BIO Recent Developments
  109. 8.19 PULIKE BIOLOGICAL ENGINERING,INC.
  110. 8.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Company Information
  111. 8.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Business Overview
  112. 8.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  114. 8.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Swine Reproductive and Respiratory Syndrome Vaccine Value Chain Analysis
  2. 9.1.1 Swine Reproductive and Respiratory Syndrome Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Swine Reproductive and Respiratory Syndrome Vaccine Production Mode & Process
  6. 9.2 Swine Reproductive and Respiratory Syndrome Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Swine Reproductive and Respiratory Syndrome Vaccine Distributors
  9. 9.2.3 Swine Reproductive and Respiratory Syndrome Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst